Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01046396 · ClinicalTrials.gov registry record · Phase 1
Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
A Phase 1 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 1
- Development phase
- 69
- Enrollment target
NCT01046396 is a Phase 1 study that has completed, run by Galderma R&D. The registered enrollment target is 69 participants.
The verdict
NCT01046396, a Phase 1 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the tolerability of Differin® (adapalene) Cream, 0.1% to Differin® Lotion, 0.1% in subjects with healthy skin treated once a day for three (3) weeks.
Interventions
- DRUG adapalene lotion 0.1%
- DRUG adapalene cream 0.1% and adapalene lotion 0.1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01046396
The ClinicalTrials.gov registry entry for NCT01046396 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which adapalene lotion 0.1% is the first listed.
NCT01046396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01046396 about?
NCT01046396 is a clinical study titled "Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin". The purpose of this study is to compare the tolerability of Differin® (adapalene) Cream, 0.1% to Differin® Lotion, 0.1% in subjects with healthy skin treated once a day for three (3) weeks.
What is the current status of trial NCT01046396?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 69 participants. The study started on 2010-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01046396?
The interventions under investigation include: adapalene lotion 0.1% (DRUG), adapalene cream 0.1% and adapalene lotion 0.1% (DRUG).
Who is sponsoring clinical trial NCT01046396?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.